Caspase-9

From WikiMD's WELLNESSPEDIA

Signal transduction pathways involving caspase-9

Caspase-9 is a crucial cysteine-aspartic protease involved in the apoptosis pathway, specifically in the intrinsic or mitochondrial pathway. It plays a significant role in the regulation of programmed cell death, which is essential for maintaining cellular homeostasis and development.

Structure[edit]

Caspase-9 is synthesized as an inactive zymogen known as procaspase-9. It consists of a prodomain, a large subunit, and a small subunit. Upon activation, the prodomain is cleaved, and the large and small subunits form the active enzyme.

Activation[edit]

Caspase-9 is activated in response to mitochondrial signals. The release of cytochrome c from the mitochondria into the cytosol is a key event in this process. Cytochrome c binds to Apaf-1 (apoptotic protease activating factor 1) in the presence of ATP, forming the apoptosome.

Apoptosome Formation[edit]

The apoptosome is a multi-protein complex that recruits and activates procaspase-9. The formation of the apoptosome is a critical step in the intrinsic pathway of apoptosis. Once activated, caspase-9 cleaves and activates downstream effector caspases, such as caspase-3 and caspase-7, leading to the execution phase of apoptosis.

Function[edit]

Caspase-9 is primarily involved in the initiation phase of the intrinsic apoptotic pathway. It acts as an initiator caspase, which means it is responsible for the activation of effector caspases. This activation cascade results in the systematic dismantling of cellular components, ultimately leading to cell death.

Regulation[edit]

The activity of caspase-9 is tightly regulated by several mechanisms:

  • Inhibitors of Apoptosis Proteins (IAPs): These proteins can bind to and inhibit caspase-9 activity.
  • Smac/DIABLO: This protein is released from the mitochondria and can neutralize IAPs, promoting caspase-9 activity.
  • Phosphorylation: Caspase-9 can be phosphorylated by kinases such as Akt, which inhibits its activity.

Clinical Significance[edit]

Dysregulation of caspase-9 activity is implicated in various diseases. Overactive caspase-9 can lead to excessive cell death, contributing to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Conversely, insufficient caspase-9 activity can result in the survival of damaged cells, potentially leading to cancer.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.